Gordon Reid, president and CEO of Goodreid Investment Counsel

Focus: U.S. equities
_______________________________________________________________

MARKET OUTLOOK
It’s ironic that in a $25-trillion public market that so little attention is paid to the primary support mechanism: Corporate earnings. After five quarters of earnings growth declines, ending in late 2016, the corporate profit train is again on the rails. First quarter earnings grew a solid 15 per cent year over year and 2017 is expected to achieve a 10 per cent+ outcome. Valuations stay reasonable if the fundamentals of a market keep pace with price, so pay as much attention to the “E” as the “P” in the P/E ratio.

TOP PICKS

Gordon Reid's Top Picks

In his Market Call Minute, Gordon Reid, president and CEO of Goodreid Investment Counsel, shares his top picks: CVS Health, Masonite and PacWest Bancorp.

CVS HEALTH (CVS.N) – Latest purchase June 2017 at $79
CVS has had a tough year, first losing sizable contracts to a rival and more recently being subjected to rumours that Amazon is going to invade the pharmacy space. It is building back business and with one billion prescriptions filled per year through almost 10,000 locations, it is a powerhouse. The complexity of a regulated business that does 99 per cent of its pharmaceutical sales with third-party payers creates a fairly wide competitive moat.

MASONITE (DOOR.N) – Latest purchase June 2017 at $76
Masonite is a leading worldwide manufacturer of interior and exterior doors, having last year achieved sales of 35 million doors in 65 countries. Margins and profitability ratios are steadily improving and business looks to be robust with household formation numbers steadily advancing.

PACWEST  BANCORP (PACW.O) – Latest purchase June 2017 at $49
PACW is a California-based bank with about 80 branches. It has grown through acquisition and primarily serves the commercial markets, both real estate and lending. With a four per cent dividend yield and attractive valuations on book value and earnings, this is an attractive entry point.
 

DISCLOSURE PERSONAL FAMILY PORTFOLIO/FUND
CVS N N Y
DOOR N N Y
PACW N N Y


PAST PICKS: JUNE 15, 2016

Gordon Reid's Past Picks

Gordon Reid, president and CEO of Goodreid Investment Counsel, reviews his past picks: Time Warner, Citigroup and Toll Brothers.

TIME WARNER (TWX.N) – Sold on March 20, 2017 at $98.50

  • Then: $72.88
  • Now: $99.21
  • Return: 36.12%
  • TR: 38.54%

CITIGROUP (C.N)

  • Then: $42.01
  • Now: $63.88
  • Return: 52.05%
  • TR: 53.96%

TOLL BROTHERS (TOL.N)

  • Then: $27.53
  • Now: $39.03
  • Return: 41.77%
  • TR: 42.08%

TOTAL RETURN AVERAGE: 44.86%
 

DISCLOSURE PERSONAL FAMILY PORTFOLIO/FUND
TWX N N N
C N N Y
TOL N N Y


FUND PROFILE: GOODREID NORTH AMERICAN BALANCED
Goodreid’s balanced approach allows investors to participate in the potential growth of equity holdings while mitigating risk through ownership of quality fixed income instruments.

PERFORMANCE AS OF MARCH 31, 2017:

  • 1 year: Fund* 11.4%, Index** 11.3%
  • 3 years: Fund* 7.4%, Index** 4.9%
  • 5 years: Fund* 9.9%, Index** 6.8%

* Returns are based on reinvested dividends and are net of fees
** Index: Globe Canadian Equity Balanced Peer Index


TOP HOLDINGS AND WEIGHTINGS

  1. Canadian equities : 34%
  2. U.S. equities: 37%
  3. Canadian fixed income: 24%
  4. Cash : 5%


WEBSITE: www.goodreid.com